Examining PTSD Symptoms in Patients Undergoing HCT – ASH Clinical News
Examining PTSD Symptoms in Patients Undergoing HCT – On Location, Other Meetings – ASH Clinical News
Related Articles
FDA Approves Hemophilia A and B Therapy | ASH Clinical News | American Society of Hematology
The U.S. Food and Drug Administration (FDA) approved fitusiran for prophylaxis to prevent or reduce bleeding episode frequency in adult and pediatric patients 12 years…
Zanubrutinib Plus Venetoclax Shows Efficacy in Treatment-Naïve CLL | ASH Clinical News | American Society of Hematology
Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. The combination of the BTK inhibitor zanubrutinib and the BCL2 inhibitor venetoclax…
Cell-of-Origin, CNS-IPI Scores Help Predict Secondary CNS Lymphoma Risk in DLBCL | ASH Clinical News | American Society of Hematology
Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. In the current era of molecular profiling and newer treatments, cell-of-origin (COO)…
MRD-Guided Approaches Yield Good Results With IsaKRD in MM | ASH Clinical News | American Society of Hematology
Thomas R. Collins is a medical journalist based in West Palm Beach, Florida. With measurable residual disease status (MRD) used as guidance, patients with newly…
Large Database Study Maps Treatment Use Among Elderly, Veteran Patients With DLBCL | ASH Clinical News | American Society of Hematology
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. Most U.S. veterans aged 80 and older diagnosed with diffuse…
Itacitinib Prophylaxis Reduces the Incidence of CRS, ICANS in IEC Therapy | ASH Clinical News | American Society of Hematology
Khylia Marshall is a freelance journalist based in Tucson, Arizona. Chimeric antigen receptor (CAR) T-cell therapy can induce long-term remission in patients with relapsed or…
June 2025 | ASH Clinical News | American Society of Hematology
June 2025 | ASH Clinical News | American Society of Hematology June 2025 Paging Dr. Well-Being Chief wellness officers address systemic pain points in the…
BCMA-Targeting CAR-T With Innovative Manufacturing Process Shows Early Activity for R/R MM | ASH Clinical News | American Society of Hematology
Leah Lawrence is a freelance health writer and editor based in Delaware. The B-cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T-cell therapy BMS-986354 demonstrated…
ASH Clinical News: June 2025 From the Desk Of…
Editor-in-Chief Aaron Gerds, MD, previews what’s to come in the next issue of ASH Clinical News. Highlights of the June issue include a feature article…
Health Care Harmed | ASH Clinical News | American Society of Hematology
Mary Ellen Schneider is a medical journalist based in Setauket, New York. The beginning of President Donald J. Trump’s second term has created a climate…